Vigabatrin Oral Solution shortage
To Be DiscontinuedVigabatrin Oral Solution is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.
Therapeutic category
Dosage form
Oral Solution
Routes
—
Last updated
10/16/2025
Strength variants
- Not specified
Need sourcing help for Vigabatrin Oral Solution?
Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.
Connect with a sourcing partnerManufacturers reporting shortage
- Pyros Pharmaceuticals, Inc.763-315-2000To Be Discontinued
Reason for shortage
ad slot 300x250
Related shortages in Neurology
Lorazepam Injection
- Category
- Neurology
- Reason
- Demand increase for the drug
- Updated
- 04/02/2026
Valproate Sodium Injection
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/02/2026
Lorazepam Injection
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/02/2026
Riluzole Oral Suspension
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/01/2026
Clonazepam Tablet
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/01/2026
Clonazepam Tablet
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/01/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.